HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

Andrea De Luca, K. Theys, J. Vercauteren, J. Snoeck, M. Zazzi, R. J. Camacho, C. Torti, E. Schülter, B. Clotet, A. De Luca, Z. Grossman, D. Struck, A. M. Vandamme, A. B. Abecasise

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Subtype-dependent selection of HIV-1 reverse transcriptase resistance mutation K65R was previously observed in cell culture and small clinical investigations. We compared K65R prevalence across subtypes A, B, C, F, G, and CRF02_AG separately in a cohort of 3,076 patients on combination therapy including tenofovir. K65R selection was significantly higher in HIV-1 subtype C. This could not be explained by clinical and demographic factors in multivariate analysis, suggesting subtype sequence-specific K65R pathways.
Original languageEnglish
Pages (from-to)1053-1056
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume57
DOIs
Publication statusPublished - 2013

Keywords

  • mutation
  • subtype

Fingerprint

Dive into the research topics of 'HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir'. Together they form a unique fingerprint.

Cite this